Glucagon-Like Peptide 1 Attenuates Lipotoxicity-Induced Islet Dysfunction in ApoE^–/– Mice

References

• Tang SM, Yang, ZM, Chen, WQ, et al. Acad J Sec Milit Med Univ. Astragalus polysaccharide improves type 2 diabetes mellitus in rats by protecting islet β cells. 2017;38(4):482–487.
   Google Scholar
• Wang WH, Guo, D.Z., Yang, S.J, et al. Activity of iNOS and cNOS in serum and lung of broilers with pulmonary hypertension syndrome. Acta Veterinaria Et Zootechnica Sinica. 2006;37(7):711–716.
   Google Scholar
• Bellinger DA, Merricks EP, Nichols TC. Swine models of type 2 diabetes mellitus: insulin resistance, glucose tolerance, and cardiovascular complications. ILAR J. 2006;47(3):243–258. doi:10.1093/ilar.47.3.243
   PubMed Web of Science ®Google Scholar
• Haffner SM. Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance. Am J Cardiol. 2002;90(8–supp–S):55–61. doi:10.1016/S0002-9149(02)02634-6
   Google Scholar
• Ahmad W, Ijaz B, Shabbiri K, et al. Oxidative toxicity in diabetes and Alzheimer’s disease: mechanisms behind ROS/RNS generation. J Biomed Sci. 2017;24(1):76. doi:10.1186/s12929-017-0379-z
   PubMedGoogle Scholar
• Hayden MR, Tyagi SC. Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformation. Cardiovasc Diabetol. 2004;3(1):1. doi:10.1186/1475-2840-3-1
   PubMedGoogle Scholar
• Husebye ES, Winqvist, O, Sundkvist, G, et al. Autoantibodies against adrenal medulla in type 1 and type 2 diabetes mellitus: no evidence for an association with autonomic neuropathy. Acta Physiol. 1996;239(2):139–146.
   Google Scholar
• Soskic SS. Regulation of Inducible Nitric Oxide Synthase (iNOS) and its Potential Role in Insulin Resistance, Diabetes and Heart Failure. Open Cardiovasc Med J. 2011;5(1):153–163. doi:10.2174/1874192401105010153
   PubMedGoogle Scholar
• Hallemeesch MM, Janssen, B.J., de Jonge, W.J, et al. NO production by cNOS and iNOS reflects blood pressure changes in LPS-challenged mice. Am J Physiol. 2003;189(9):161–166.
   Google Scholar
• Diefenbach J, Bürkle A. Introduction to poly(ADP-ribose) metabolism. Cell mol life sci. 2005;62(7–8):721–730.
   PubMedGoogle Scholar
• Sharp C, Warren A, Oshima T, et al. Poly ADP ribose-polymerase inhibitors prevent the upregulation of ICAM-1 and E-selectin in response to Th1 cytokine stimulation. Inflammation. 2001;25(3):157–163. doi:10.1023/A:1011032313445
   PubMedGoogle Scholar
• Salehi A, Ekelund M, Henningsson R, et al. Total parenteral nutrition modulates hormone release by stimulating expression and activity of inducible nitric oxide synthase in rat pancreatic islets. Endocrine. 2001;16(2):97–104. doi:10.1385/ENDO:16:2:097
   PubMed Web of Science ®Google Scholar
• Jimenez-Feltstrom J, Lundquist I, Salehi A. Glucose stimulates the expression and activities of nitric oxide synthases in incubated rat islets: an effect counteracted by GLP-1 through the cyclic AMP/PKA pathway. Cell Tissue Res. 2005;319(2):221–230. doi:10.1007/s00441-004-1013-4
   PubMedGoogle Scholar
• Henningsson R, Salehi A, Lundquist I. Role of nitric oxide synthase isoforms in glucose-stimulated insulin release. Am J Physiol Cell Physiol. 2002;283(1):C296–C304. doi:10.1152/ajpcell.00537.2001
   PubMed Web of Science ®Google Scholar
• Drucker DJ. Glucagon-like peptide-1 and the islet β-cell: augmentation of cell proliferation and inhibition of apoptosis. Endocrinology. 2003;144(12):5145–5148. doi:10.1210/en.2003-1147
   PubMed Web of Science ®Google Scholar
• Kuhre RE, Wewer Albrechtsen NJ, Hartmann B, et al. Measurement of the incretin hormones: glucagon-like peptide-1 and glucose-dependent insulinotropic peptide. J Diabetes Complications. 2015;29(3):445–450. doi:10.1016/j.jdiacomp.2014.12.006
   PubMed Web of Science ®Google Scholar
• Lim DM, Park, K.Y., Hwang, W.M, et al. Difference in protective effects of GIP and GLP?1 on endothelial cells according to cyclic adenosine monophosphate response. Exp Ther Med. 2017;13(5):2558–2564.
   PubMedGoogle Scholar
• Ito T, Nagaoka K, Nagaoka K, et al. Relationship of particulate matter and ozone with 3-nitrotyrosine in the atmosphere. Environ Pollut. 2018;236:948. doi:10.1016/j.envpol.2017.10.069
   PubMedGoogle Scholar
• Hui YWM, Zhao SS, Love JA, Ansley DM, Chen DD, Chen DDY. A simple and robust LC-MS/MS method for quantification of free 3-nitrotyrosine in human plasma from patients receiving on-pump CABG surgery. Electrophoresis. 2012;33(4):697–704. doi:10.1002/elps.201100368
   PubMedGoogle Scholar
• Itoh N, Hanafusa, T., Miyazaki, A, et al. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J clin invest. 1993;92(5):2313–2322.
   PubMedGoogle Scholar
• Mather KJ, Considine RV, Hamilton L, et al. Combination GLP-1 and insulin treatment fails to alter myocardial fuel selection vs. insulin alone in type 2 diabetes. J Clin Endocrinol Metab. 2018;103(9):3456–3465. doi:10.1210/jc.2018-00712
   PubMedGoogle Scholar
• Nystrom T. Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease. AJP. 2004;287:E1209.
   PubMedGoogle Scholar
• Isabel DO-GM, Francisco M-TJ. GLP-1 Receptor Agonists and Cardiovascular Disease in Patients with Type 2 Diabetes. J Diabetes Res. 2018;1–12.
   Google Scholar
• Tomita T. Apoptosis in pancreatic β-islet cells in Type 2 diabetes. Bosnian J Basic Med Sci. 2016;16:162.
   PubMed Web of Science ®Google Scholar
• Klöppel G, Löhr, M., Habich, K, et al. Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Survey synthesis pathol res. 1985;4(2):110–125.
   PubMedGoogle Scholar
• Porte D. β-cells in type II diabetes mellitus. Diabetes. 1991;40(2):166–180. doi:10.2337/diab.40.2.166
   PubMedGoogle Scholar
• Sun L, et al. Novel pentapeptide GLP‐ 1(32‐36)amide inhibits β‐cell apoptosis in vitro and improves glucose disposal in streptozotocin‐induced diabetic mice. Chem Biol Drug Design. 2016;86(6):1482–1490.
   Google Scholar
• Unger RH. The banting memorial lecture 1975: diabetes and the alpha cell. Diabetes. 1976;25(2):136–151. doi:10.2337/diab.25.2.136
   PubMedGoogle Scholar
• Cieślar-Pobuda A, Saenko Y, Rzeszowska-Wolny J. Rzeszowska-Wolny, PARP-1 inhibition induces a late increase in the level of reactive oxygen species in cells after ionizing radiation. Mutat Res. 2012;732(1–2):9–15. doi:10.1016/j.mrfmmm.2012.01.005
   PubMedGoogle Scholar
• Yang W, Lu J, Weng J, et al. Prevalence of Diabetes among Men and Women in China. N Eng J Med. 2010;362(12):1090–1101. doi:10.1056/NEJMoa0908292
   PubMed Web of Science ®Google Scholar
• Nakhjavani M, Khalilzadeh, O., Khajeali, L, et al. Serum Oxidized-LDL is Associated with Diabetes Duration Independent of Maintaining Optimized Levels of LDL-Cholesterol. Lipids. 2018;454:321–327.
   Google Scholar
• Yu Z, Kuncewicz T, Dubinsky WP, et al. Nitric Oxide-dependent Negative Feedback of PARP-1 trans-Activation of the Inducible Nitric-oxide Synthase Gene. J Biol Chem. 2006;281(14):9101–9109. doi:10.1074/jbc.M511049200
   PubMed Web of Science ®Google Scholar
• Perrotta I, Brunelli, E., Sciangula, A, et al. iNOS induction and PARP-1 activation in human atherosclerotic lesions: an immunohistochemical and ultrastructural approach. Cardiovasc Pathol. 2018;20(4):0–203.
   Google Scholar
• Harris RC, et al. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J clin invest. 1994;94(6):2504–2510.
   PubMed Web of Science ®Google Scholar
• Tetsuka T, Daphna-Iken D, Miller BW, et al. Nitric oxide amplifies interleukin 1 induced cyclooxygenase 2 expression in rat mesangial cells. J Clin Invest. 1996;97(9):2051–2056. doi:10.1172/JCI118641
   PubMed Web of Science ®Google Scholar
• Fletcher BS, Kujubu, D.A., Perrin, D.M, et al. Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase. J Biol Chem. 1992;267:4338.
   PubMed Web of Science ®Google Scholar
• Wang Z-Q, Chen, M.T., Zhang, R, et al. Docosahexaenoic acid attenuates doxorubicin-induced cytotoxicity and inflammation by suppressing NF-κB/iNOS/NO signaling pathway activation in H9C2 cardiac cells. J Cardiovasc Pharmacol. 2015;67(4):1.
   Google Scholar